Mofecon OS Oral Suspension
Mofecon OS Oral Suspension
Mycophenolate mofetil (1gm/5ml)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Mofecon OS Oral Suspension is a medication used to prevent rejection in patients with renal transplant. It contains mycophenolate mofetil, a prodrug that is converted to mycophenolic acid (MPA) in the gastrointestinal tract. MPA is a potent immunosuppressant that inhibits the proliferation of activated T and B cells, thereby reducing the risk of allograft rejection. The oral suspension is administered once or twice daily, depending on the patient's weight and individual requirements. The recommended dose is 1000mg to 2000mg per day, divided into two or three doses. Patients should start treatment on the day of transplantation and continue for at least six months. Common adverse effects include diarrhea, gastrointestinal upset, and increased risk of infections. Mofecon OS Oral Suspension is contraindicated in patients with hypersensitivity to mycophenolate mofetil or other immunosuppressive agents. It is essential to monitor patients for signs of rejection, infection, and laboratory abnormalities during treatment.
Active composition
Mycophenolate mofetil
About Mycophenolate mofetil
Mycophenolate mofetil is an immunosuppressant used primarily to prevent organ rejection in transplant patients, such as kidney, heart, or liver recipients. It works by inhibiting the proliferation of lymphocytes, which are crucial for the immune response. By suppressing the immune system, Mycophenolate mofetil helps the body accept the transplanted organ and reduces the risk of rejection. This medication is essential for improving transplant success rates. In summary, Mycophenolate mofetil is critical for organ transplant management.
How It Works
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), leading to decreased lymphocyte proliferation and immune response.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Mofecon OS Oral Suspension is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Mofecon OS Oral Suspension is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Driving
Mofecon OS Oral Suspension should be used with caution in patients with severe kidney disease. Dose adjustment of Mofecon OS Oral Suspension may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Mofecon OS Oral Suspension does not usually affect your ability to drive.
Consult Doctor
Kidney
There is limited information available on the use of Mofecon OS Oral Suspension in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mofecon OS Oral Suspension
